Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6493
    -0.0008 (-0.12%)
     
  • OIL

    82.68
    -0.13 (-0.16%)
     
  • GOLD

    2,332.90
    -5.50 (-0.24%)
     
  • Bitcoin AUD

    97,528.93
    -4,207.47 (-4.14%)
     
  • CMC Crypto 200

    1,364.57
    -18.01 (-1.30%)
     
  • AUD/EUR

    0.6068
    -0.0002 (-0.03%)
     
  • AUD/NZD

    1.0955
    +0.0013 (+0.12%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,233.75
    -293.05 (-1.67%)
     
  • FTSE

    8,054.17
    +13.79 (+0.17%)
     
  • Dow Jones

    37,867.14
    -593.78 (-1.54%)
     
  • DAX

    17,844.18
    -244.52 (-1.35%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

The Best Stocks to Invest $5,000 In Right Now

The Best Stocks to Invest $5,000 In Right Now

The stock market has already marked its fair share of high highs and low lows in 2023, and we're not even a full month in. Vertex Pharmaceuticals (NASDAQ: VRTX) isn't one of those healthcare stocks with a massive portfolio of drugs that has tapped out its heyday of superior growth. At present, Vertex has just four approved drugs in its portfolio, and all of them treat the genetic disease cystic fibrosis.